Preclinical models in the study of sex differences

Author:

Buoncervello Maria1,Marconi Matteo2,Carè Alessandra3,Piscopo Paola4,Malorni Walter25,Matarrese Paola25

Affiliation:

1. Section of Experimental Immunotherapy, Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy

2. Section of Gender Medicine, Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy

3. Section of Molecular Oncology, Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy

4. Section of Clinical, Diagnosis and Therapy of CNS Degenerative Diseases, Department of Neurosciences, Istituto Superiore di Sanità, 00161 Rome, Italy

5. Center of Gender-Specific Medicine, Istituto Speriore di Sanita', 00161 Rome, Italy

Abstract

The biology of sex differences deals with the study of the disparities between females and males and the related biological mechanisms. Gender medicine focuses on the impact of gender and sex on human physiology, pathophysiology and clinical features of diseases that are common to women and men. The term gender refers to a complex interrelation and integration of sex–as a biological and functional determinant–and psychological and cultural behaviours (due to ethnical, social or religious background). The attention to the impact of gender differences on the pathophysiology and, therefore, on the clinical management of the most common diseases, such as cardiovascular diseases (CVD), neurodegenerative disorders, immune and autoimmune diseases as well as several tumours, is in fact often neglected. Hence, studies covering different fields of investigation and including sex differences in the pathogenesis, in diagnostic and prognostic criteria as well as in response to therapy appear mandatory. However, prerequisites for this development are preclinical studies, including in vitro and in vivo approaches. They represent the first step in the development of a drug or in the comprehension of the pathogenetic mechanisms of diseases, in turn a necessary step for the development of new or more appropriate therapeutic strategies. However, sex differences are still poorly considered and the great majority of preclinical studies do not take into account the relevance of such disparities. In this review, we describe the state of the art of these studies and provide some paradigmatic examples of key fields of investigation, such as oncology, neurology and CVD, where preclinical models should be improved.

Publisher

Portland Press Ltd.

Subject

General Medicine

Reference105 articles.

1. Sex and gender differences in health. Science & Society Series on Sex and Science;Regitz-Zagrosek;EMBO Rep.,2012

2. Sex and gender differences in clinical medicine;Regitz-Zagrosek;Handb. Exp. Pharmacol.,2012

3. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes;Regitz-Zagrosek;Eur. Heart J.,2016

4. Gender specific aspects of cell death in the cardiovascular system;Pierdominici;Curr. Pharm. Des.,2011

5. Sex beyond the genitalia: the human brain mosaic;Joel;Proc. Natl. Acad. Sci. U.S.A.,2015

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3